<?xml version="1.0" encoding="UTF-8"?>
<p>Acute myeloid leukemia (AML) is the most common acute leukemia in adults, and incidence correlates with age. Older (&gt;60 years) patients with AML typically have poorer prognoses and outcomes compared with younger patients, with response rates ≤50% to conventional treatments frequently reported, and few patients survive &gt;2 years.
 <xref rid="ajh25238-bib-0001" ref-type="ref">1</xref>, 
 <xref rid="ajh25238-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="ajh25238-bib-0003" ref-type="ref">3</xref>, 
 <xref rid="ajh25238-bib-0004" ref-type="ref">4</xref>, 
 <xref rid="ajh25238-bib-0005" ref-type="ref">5</xref>, 
 <xref rid="ajh25238-bib-0006" ref-type="ref">6</xref>, 
 <xref rid="ajh25238-bib-0007" ref-type="ref">7</xref>, 
 <xref rid="ajh25238-bib-0008" ref-type="ref">8</xref>
</p>
